- Home
- TXMD vs GOODO Comparison
TXMD vs GOODO Comparison
Compare TXMD & GOODO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- GOODO
- Stock Information
- Founded
- TXMD 2008
- GOODO N/A
- Country
- TXMD United States
- GOODO United States
- Employees
- TXMD N/A
- GOODO 72
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- GOODO Real Estate
- Sector
- TXMD Health Care
- GOODO Real Estate
- Exchange
- TXMD Nasdaq
- GOODO Nasdaq
- Market Cap
- TXMD 12.8M
- GOODO N/A
- IPO Year
- TXMD N/A
- GOODO N/A
- Fundamental
- Price
- TXMD $1.13
- GOODO $20.43
- Analyst Decision
- TXMD
- GOODO
- Analyst Count
- TXMD 0
- GOODO 0
- Target Price
- TXMD N/A
- GOODO N/A
- AVG Volume (30 Days)
- TXMD 60.3K
- GOODO N/A
- Earning Date
- TXMD 08-11-2025
- GOODO N/A
- Dividend Yield
- TXMD N/A
- GOODO N/A
- EPS Growth
- TXMD N/A
- GOODO N/A
- EPS
- TXMD N/A
- GOODO N/A
- Revenue
- TXMD $1,841,000.00
- GOODO N/A
- Revenue This Year
- TXMD $427.09
- GOODO N/A
- Revenue Next Year
- TXMD N/A
- GOODO N/A
- P/E Ratio
- TXMD N/A
- GOODO N/A
- Revenue Growth
- TXMD 53.55
- GOODO N/A
- 52 Week Low
- TXMD $0.70
- GOODO N/A
- 52 Week High
- TXMD $2.44
- GOODO N/A
- Technical
- Relative Strength Index (RSI)
- TXMD 44.02
- GOODO 47.73
- Support Level
- TXMD $1.07
- GOODO $20.21
- Resistance Level
- TXMD $1.21
- GOODO $20.64
- Average True Range (ATR)
- TXMD 0.09
- GOODO 0.16
- MACD
- TXMD 0.00
- GOODO -0.04
- Stochastic Oscillator
- TXMD 54.68
- GOODO 35.50
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.